Solos Endoscopy, Inc. To Launch New Corporate Website
Poster: SySAdmin
Posted on June 23, 2011 at 8:42:01 AM
Solos Endoscopy, Inc. To Launch New Corporate Website
BOSTON, June 23, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce the launch of their newly designed and interactive website, http://www.solosendoscopy.com on Friday July 1, 2011. The online venue serves as a "virtual catalog" for existing and new customers and includes comprehensive information for shareholders, investors and potential partners alike. The updated look showcases streamlined navigation to allow for easy-to-use functionality, allowing users to quickly reference desired information making it easier for Hospitals, Clinics, Healthcare Centers, Medical Centers and Surgery Centers across the United States to identify and select from Solos' vast product line.
The website features a clean design with organized descriptions covering the entire scope of the Company's business and product categories. Users are presented with an overview of the Company, recent news and direct links to the Company's OTC Markets filings as well as detailed listings and information on the assortment of endoscopic instrumentation and medical imaging solutions Solos has to offer. Also under development and coming soon, are links to Solos' Social Media assets including; Twitter, Facebook, LinkedIn and Stumbled Upon amongst others.
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Solos Endoscopy's MammoView® system, the Company's flagship product line, employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.
"We are aware that people are constantly searching the web for more in-depth knowledge and overall better detailed information," stated Bob Segersten, President of Solos Endoscopy, Inc. "With the launch, we strived to provide a website that is rich in technical and visual content, while providing an easy-to-navigate interface for the HealthCare community we serve."
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: http://www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
Solos Endoscopy, Inc.
CONTACT: Investor Relations, +1-407-389-5900
Web Site: http://www.solosendoscopy.com
BOSTON, June 23, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce the launch of their newly designed and interactive website, http://www.solosendoscopy.com on Friday July 1, 2011. The online venue serves as a "virtual catalog" for existing and new customers and includes comprehensive information for shareholders, investors and potential partners alike. The updated look showcases streamlined navigation to allow for easy-to-use functionality, allowing users to quickly reference desired information making it easier for Hospitals, Clinics, Healthcare Centers, Medical Centers and Surgery Centers across the United States to identify and select from Solos' vast product line.
The website features a clean design with organized descriptions covering the entire scope of the Company's business and product categories. Users are presented with an overview of the Company, recent news and direct links to the Company's OTC Markets filings as well as detailed listings and information on the assortment of endoscopic instrumentation and medical imaging solutions Solos has to offer. Also under development and coming soon, are links to Solos' Social Media assets including; Twitter, Facebook, LinkedIn and Stumbled Upon amongst others.
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Solos Endoscopy's MammoView® system, the Company's flagship product line, employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.
"We are aware that people are constantly searching the web for more in-depth knowledge and overall better detailed information," stated Bob Segersten, President of Solos Endoscopy, Inc. "With the launch, we strived to provide a website that is rich in technical and visual content, while providing an easy-to-navigate interface for the HealthCare community we serve."
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: http://www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
Solos Endoscopy, Inc.
CONTACT: Investor Relations, +1-407-389-5900
Web Site: http://www.solosendoscopy.com